Presidential Award - Peer Reviewed Publication

Prize: Prize (including medals and awards)

Description

A Phase 1/2 Clinical Trial of the Nitric Oxide Synthase Inhibitor L-NMMA and Taxane for Treating Chemoresistant Triple-Negative Breast Cancer
Awarded date2022

    Fingerprint